Alterations in peripheral T‐ and B‐cell subsets in patients with systemic sclerosis

Abstract Objectives To determine the alteration of peripheral T and B cell subsets in patients with systemic sclerosis (SSc) and to evaluate their correlation with the progression of SSc. Methods We recruited 47 SSc patients and 45 healthy controls (HCs) in this study. Demographic and clinical data were then collected. Flow cytometry was used to detect the proportions of 44 different T and B cell subsets in circulating blood. Results The proportion of total B cells ( p = .043) decreased in SSc patients, together with similar frequencies of total T cells, CD4+ T cells, and CD8+ T cells in both groups. Several subsets of T and B cells differed significantly between these two groups. Follicular helper T cells‐1 (Tfh1) ( p < .001), helper T cells‐1 (Th1) ( p = .001), regulatory T cells (Treg) ( p = .004), effector memory CD8+ T cells ( p = .041), and cytotoxic T cells‐17 (Tc17) ( p = .01) were decreased in SSc patients. Follicular helper T cells‐2 (Tfh2) ( p = .001) and, helper T cells‐2 (Th2) ( p = .001) levels increased in the SSc group. Regulatory B cells (Breg) ( p = .015) were lower in the SSc group, together with marginal zone (MZ) B cells ( p < .001), memory B cells ( p = .001), and non‐switched B cells ( p = .005). The modified Rodnan skin score (mRSS) correlated with helper T cells‐17 (Th17) ( r = −.410, p = .004), Tfh1 ( r = −.321, p = .028), peripheral helper T cells (Tph) ( r = −.364, p = .012) and plasma cells ( r = −.312, p = .033). Conclusions The alterations in T and B cells implied immune dysfunction, which may play an essential role in systemic sclerosis.